Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...
Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible ...
Hosted on MSN8d
Altria Just Paid Investors: Here’s How Much They ReceivedAltria Group Inc. (NYSE: MO) is rewarding its shareholders once again with a quarterly dividend of $1.02, payable on Friday, ...
In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price ...
The newest nicotine product comes in multiple different flavors and is growing in popularity among teenagers. Zen is *** tiny ...
Hosted on MSN3d
Altria Group Earnings Preview: What to ExpectAltria Group, Inc. (MO), headquartered in Richmond, Virginia, is a leading producer and seller of smokeable and oral tobacco ...
The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback